Thousand Asian American Study
NCT02596438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1076
Last updated 2017-10-31
Summary
The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.
Conditions
Interventions
- OTHER
-
Hepatitis B Surface Antigen, Hepatitis B Surface Antibody and Hepatitis B Core AB, Total Testing
Sponsors & Collaborators
-
University of California, Davis
lead OTHER
Principal Investigators
-
Moon S Chen Jr., PhD · UC Davis Comprehensive Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-01
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus
NCT04065230 ·Status: UNKNOWN
-
Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)
NCT05177926 ·Status: UNKNOWN ·Phase: PHASE4
-
TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
NCT05195450 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment
NCT02296853 ·Status: COMPLETED ·Phase: PHASE1
-
Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
NCT05410496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)
NCT00651209 ·Status: COMPLETED ·Phase: PHASE4
-
TAF to Prevent HBV Reactivation in Cancer Patients
NCT04619082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
TAF Real World Study for Universal Effectiveness
NCT03752658 ·Status: UNKNOWN
-
The Efficacy and Safety of TAF vs Other NAs in Patients With LVL
NCT04501224 ·Status: UNKNOWN ·Phase: NA
-
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
NCT03519113 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
NCT07307586 ·Status: RECRUITING ·Phase: PHASE3
-
Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
NCT02995005 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
NCT00646503 ·Status: COMPLETED ·Phase: PHASE4
-
Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
NCT00800787 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
NCT03692897 ·Status: TERMINATED
-
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B
NCT00781105 ·Status: COMPLETED ·Phase: PHASE4
-
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
NCT04850950 ·Status: UNKNOWN ·Phase: PHASE4
-
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B
NCT00115245 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection
NCT04507607 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
NCT02738008 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
NCT03471624 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
NCT00513968 ·Status: COMPLETED ·Phase: PHASE1
-
Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir
NCT05423834 ·Status: ACTIVE_NOT_RECRUITING